Our premium News+ ad-free experience – only $10 more every 4 weeks!

An article published on a medical website Medscape Today was entitled “Minnesota Bill Against Vaccines Promotes ...

In terms of liquidity and interest, the mean open interest for Moderna options trades today is 1389.55 with a total volume of ...

HealthDay News — Urticaria is seen in association with experimental HIV-1 mRNA vaccination, according to a study published online April 29 in the Annals of Internal Medicine.

The market closed last week mostly lower, however, the S&P 500 has been up more than 7% since April 11, indicating a ...

Back in 2020, the company announced it would give up the development of VX-814, a potential treatment for alpha-1 antitrypsin ...

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines ...

A genome-wide association study in Sweden identified rare genetic variants near the SCAF11 and LRRC4C genes that may be linked to heart inflammation following COVID-19 mRNA vaccination. The findings ...

A new trial suggests a combination vaccine may offer equal or better protection against both flu and covid-19 compared to ...

The anti-mRNA sentiment — coupled with the sweeping shake-up of science funding across the United States — has sparked fears ...

Cartesian Therapeutics, Inc.’s RNAC share price has dipped by 5.95%, which has investors questioning if this is right time to buy.

Scientists have uncovered a promising new way to enhance the effectiveness of vaccines by tapping into the potential of a specific type of immune cell, opening the door to long-lasting vaccines for ...